(Reuters) – GlaxoSmithKline Plc said on Tuesday that plaintiffs in the first scheduled U.S. lawsuit around heartburn drug Zantac will file a notice to voluntarily dismiss the...
By Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) rose on Friday, paring back some heavy recent losses, as the British pharmaceutical giant responded to a bout of...
By Senad KaraahmetovicShares of GSK (NYSE:GSK), formerly GlaxoSmithKline, are down over 8% in premarket Thursday amid mounting concerns about the recalled drug Zantac.The company...
The shares of pharma giant GSK (GB:GSK) are trading down by 7.2% in the last five days amid fears over litigation over its heartburn medicine Zantac. The company's consumer...
Sanofi, GSK Plummet After Zantac Lawsuit Concerns Wipe Out $40 Billion In ValueShares in Sanofi, GSK, and Haleon have lost a combined $40 billion in market cap since Tuesday's...
Moderna (NASDAQ:MRNA), one of the most-loved stocks this year, has lost some of its charm. Its shares are now under pressure as many analysts warn that the rally in the COVID...
GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Sell | Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 3,500.00 | 3,500.00 | 3,494.00 | 0.0 | 0.00% | 0.00 | London | |||
| 81.30 | 83.40 | 78.70 | -1.05 | -1.27% | 920.50K | London | |||
| 9.00 | 9.00 | 9.00 | -0.10 | -1.05% | 1.17M | London | |||
| 406.50 | 407.00 | 404.00 | 0.00 | 0.00% | 508.12K | London | |||
| 213.60 | 218.00 | 213.40 | -3.40 | -1.57% | 1.76M | London | |||
| 223.70 | 223.70 | 221.50 | +2.40 | +1.08% | 3.55M | London | |||
| 850.00 | 852.00 | 829.00 | +21.50 | +2.60% | 138.41K | London | |||
| 269.10 | 271.30 | 262.20 | +2.40 | +0.90% | 28.12M | London | |||
| 1,168.00 | 1,175.50 | 1,157.00 | +16.50 | +1.43% | 3.32M | London | |||
| 482.40 | 482.50 | 476.10 | 0.00 | 0.00% | 0.00 | London | |||
| 1,848.00 | 1,848.00 | 1,848.00 | 0.0 | 0.00% | 0.00 | London | |||
| 85.90 | 87.63 | 85.65 | +0.15 | +0.17% | 20.24M | London | |||
| 177.80 | 180.80 | 177.00 | -2.10 | -1.17% | 161.06K | London | |||
| 76.20 | 76.20 | 75.50 | +0.20 | +0.26% | 239.97K | London | |||
| 90.00 | 91.20 | 88.10 | -1.00 | -1.10% | 555.62K | London |